TransEnterix gaining traction with solid Senhance sales so far in 2018

Posted in Robotic Surgery,

May 08, 2018 • 2 min read

TransEnterix just announced Q1 earnings with an additional update on Senhance system sales up to this point in Q2, which ends June 30th. On initial glance, you can tell the TransEnterix sales team has done a nice job shortening the typical sales cycle for capital equipment of this dollar amount. ...

Intuitive Surgical continues to target General Surgery with inguinal hernia study

Posted in Robotic Surgery,

May 06, 2018 • 3 min read

One of Intuitive Surgical's four priorities in 2018 is to continue adoption in General Surgery. Through the first quarter of the year, the company is well on their way to over-achieving their four priorities. One way Intuitive can ensure their adoption and growth in general surgery is to show efficacy with their da Vinci versus traditional open procedures. ...

Netflix Documentary takes on the medical device industry

Posted in Robotic Surgery,

April 30, 2018 • 2 min read

Billions in sales. Millions of U.S. patients at risk. An industry that goes largely unregulated and unchecked — until now. That's how the website for the new Netflix documentary, The Bleeding Edge, describes the medical device industry. ...

TransEnterix Earnings: What Did We Learn?

Posted in Robotic Surgery,

March 08, 2018 • 3 min read

During their most recent earnings call, TransEnterix shared some notable highlights in regards to their cash position, expanded indications and the sale of two Senhance systems thus far in Q1 of 2018. ...